Pharos iBio Co., Ltd. (KOSDAQ:388870)
9,650.00
+500.00 (5.46%)
At close: Apr 1, 2026
Pharos iBio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 25,533 | 6,360 | 15,588 | 3,812 | 18,812 |
Short-Term Investments | 480.86 | 9,308 | 9,899 | 11,267 | 5,000 |
Cash & Short-Term Investments | 26,014 | 15,668 | 25,487 | 15,079 | 23,812 |
Cash Growth | 66.03% | -38.53% | 69.02% | -36.68% | 60.81% |
Accounts Receivable | -0 | 0 | 0 | 0 | -0 |
Other Receivables | 34.92 | 142.02 | 176.56 | 195.54 | 48.02 |
Receivables | 34.91 | 142.02 | 176.56 | 195.54 | 48.01 |
Prepaid Expenses | 88.61 | 72.26 | 160.37 | 167.89 | 234.56 |
Other Current Assets | 261.07 | 371.92 | 346.75 | 272.46 | 327.31 |
Total Current Assets | 26,398 | 16,254 | 26,170 | 15,715 | 24,422 |
Property, Plant & Equipment | 2,382 | 2,817 | 3,218 | 2,541 | 2,700 |
Long-Term Investments | -0 | 0 | 0.13 | 0 | -0 |
Other Intangible Assets | 373.46 | 419.08 | 148.95 | 203.04 | 264.56 |
Other Long-Term Assets | 714.69 | 137.78 | 153.17 | 262.56 | 99.59 |
Total Assets | 29,868 | 19,628 | 29,690 | 18,721 | 27,486 |
Accrued Expenses | 95.7 | 217.38 | 86.3 | 131.83 | 51.55 |
Current Portion of Long-Term Debt | - | - | - | 106.25 | 125 |
Current Portion of Leases | 149.4 | 82.11 | 177.25 | 154.31 | 151.2 |
Other Current Liabilities | 1,147 | 673.72 | 949.8 | 558.56 | 42,373 |
Total Current Liabilities | 1,392 | 973.21 | 1,213 | 950.95 | 42,700 |
Long-Term Debt | 7,731 | - | - | - | 106.25 |
Long-Term Leases | 64.27 | 41.61 | 127.7 | 105.12 | 209.17 |
Pension & Post-Retirement Benefits | - | - | - | - | 259.36 |
Other Long-Term Liabilities | 6,755 | 0 | -0 | 0 | 6.87 |
Total Liabilities | 15,943 | 1,015 | 1,341 | 1,056 | 43,282 |
Common Stock | 6,473 | 6,473 | 6,459 | 5,738 | 2,902 |
Additional Paid-In Capital | 102,155 | 102,155 | 101,927 | 83,576 | 1,307 |
Retained Earnings | -103,088 | -92,332 | -81,771 | -72,913 | -55,997 |
Comprehensive Income & Other | 8,386 | 2,317 | 1,734 | 1,264 | 604.87 |
Total Common Equity | 13,926 | 18,614 | 28,349 | 17,665 | -51,184 |
Shareholders' Equity | 13,926 | 18,614 | 28,349 | 17,665 | -15,796 |
Total Liabilities & Equity | 29,868 | 19,628 | 29,690 | 18,721 | 27,486 |
Total Debt | 7,945 | 123.72 | 304.95 | 365.68 | 591.61 |
Net Cash (Debt) | 18,069 | 15,544 | 25,182 | 14,714 | 23,221 |
Net Cash Growth | 16.24% | -38.27% | 71.15% | -36.64% | 63.31% |
Net Cash Per Share | 1395.92 | 1202.59 | 2080.94 | 1656.70 | 4001.05 |
Filing Date Shares Outstanding | 12.94 | 12.95 | 12.92 | 11.48 | 5.8 |
Total Common Shares Outstanding | 12.94 | 12.95 | 12.92 | 11.48 | 5.8 |
Working Capital | 25,006 | 15,281 | 24,957 | 14,764 | -18,278 |
Book Value Per Share | 1076.25 | 1437.79 | 2194.39 | 1539.19 | -8819.20 |
Tangible Book Value | 13,552 | 18,194 | 28,200 | 17,462 | -51,448 |
Tangible Book Value Per Share | 1047.39 | 1405.42 | 2182.86 | 1521.50 | -8864.79 |
Land | 367 | 367 | 367 | 367 | 367 |
Buildings | 782.08 | 782.08 | 782.08 | 782.08 | 782.08 |
Machinery | 2,310 | 2,373 | 1,980 | 1,445 | 1,239 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.